Complement-mediated in vitro bactericidal activity of monoclonal antibodies reactive with outer-surface-protein OspB of Borrelia burgdorferi
- PMID: 1537543
- DOI: 10.1016/0378-1097(92)90619-y
Complement-mediated in vitro bactericidal activity of monoclonal antibodies reactive with outer-surface-protein OspB of Borrelia burgdorferi
Abstract
Murine monoclonal antibodies (mAbs) were obtained against the outer-surface-protein OspA and OspB and against the 41-kDa flagellar antigen of Borrelia burgdorferi. The specificity of mAb was determined by the Western blotting technique and the surface association of the antigens was inferred by immunofluorescence of living bacteria. In an in vitro assay in the presence of complement, two mAbs reactive with the Ospa were able to kill borreliae, whereas several mAbs reactive with the OspA as well as with the 41-kDa flagellar protein were not.
Similar articles
-
Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.Infect Immun. 1994 Nov;62(11):4929-37. doi: 10.1128/iai.62.11.4929-4937.1994. Infect Immun. 1994. PMID: 7927774 Free PMC article.
-
Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement.FEMS Immunol Med Microbiol. 1993 Jun;7(1):67-71. doi: 10.1111/j.1574-695X.1993.tb00383.x. FEMS Immunol Med Microbiol. 1993. PMID: 8364524
-
Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi.Zentralbl Bakteriol. 1993 Jun;279(2):201-13. doi: 10.1016/s0934-8840(11)80398-1. Zentralbl Bakteriol. 1993. PMID: 8219491
-
Functional heterogeneity in the antibodies produced to Borrelia burgdorferi.Wien Klin Wochenschr. 1999 Dec 10;111(22-23):985-9. Wien Klin Wochenschr. 1999. PMID: 10666815 Review.
-
[Bactericidal and bacteriolytic immune reactions. Respective roles of complement and lysozyme. Their value in defense mechanisms against infection].Rev Fr Transfus. 1972 Mar;15(1):81-137. doi: 10.1016/s0035-2977(72)80031-2. Rev Fr Transfus. 1972. PMID: 4567606 Review. French. No abstract available.
Cited by
-
Development and optimization of OspC chimeritope vaccinogens for Lyme disease.Vaccine. 2020 Feb 18;38(8):1915-1924. doi: 10.1016/j.vaccine.2020.01.027. Epub 2020 Jan 17. Vaccine. 2020. PMID: 31959423 Free PMC article.
-
Specific antibodies reactive with the 22-kilodalton major outer surface protein of Borrelia anserina Ni-NL protect chicks from infection.Infect Immun. 1999 May;67(5):2633-7. doi: 10.1128/IAI.67.5.2633-2637.1999. Infect Immun. 1999. PMID: 10225933 Free PMC article.
-
Surface immunofluorescence assay for diagnosis of Lyme disease.J Clin Microbiol. 1992 Sep;30(9):2456-61. doi: 10.1128/jcm.30.9.2456-2461.1992. J Clin Microbiol. 1992. PMID: 1401015 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources